Article

Poll: Were you warned about side effects?

Author(s):

Staff

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of bald man.
Image of man.
Image of Kumar.
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
Image of Dr. Uboha.
Melanoma is a key cancer type for developing and testing immunotherapies prior to broader clinical application across other malignancies.
Image of Dr. Kumar.
Image of man
Photo of a woman with shoulder-length black hair wearing a blazer
Related Content
Dr. Rugo has led key breast cancer therapy trials and exudes a passion for serving patients.
April 18th 2025

Renowned Breast Cancer Physician-Scientist Dr. Hope S. Rugo to Lead City of Hope’s Women’s Cancers Program

City of Hope
Dr. Rugo has led key breast cancer therapy trials and exudes a passion for serving patients.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
An AI model may help identify patients with myelofibrosis at high risk of early death after transplant, according to an expert: © stock.adobe.com.
April 18th 2025

AI Tool May Better Predict Transplant Risk in Myelofibrosis

Spencer Feldman
An AI model may help identify patients with myelofibrosis at high risk of early death after transplant, according to an expert.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Image of Lungs.
April 18th 2025

First Patient Dosed in a Phase 1/2 Trial for Small Cell Lung Cancer

Ryan Scott
The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus immune checkpoint inhibitors.
The first patient with metastatic colorectal cancer has received TCMCB07 in a phase 2 trial to prevent weight loss in those undergoing chemotherapy: © stock.adobe.com.
April 18th 2025

First Patient with Colon Cancer Dosed in a Phase 2 Study of TCMCB07

Spencer Feldman
The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal cancer undergoing chemotherapy.